RDMD Secures $14 Million in Series A Financing and Announces Partnership with UCB in Rare Neurodegenerative Disease

RDMD Secures $14 Million in Series A Financing and Announces Partnership with UCB in Rare Neurodegenerative Disease

SAN FRANCISCO–(BUSINESS WIRE)–RDMD, a healthcare technology company dedicated to accelerating drug research for patients with rare diseases, today announced that it has raised $14 million in Series A financing. RDMD has developed an FDA-ready technology pla…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *